Literature DB >> 26558549

Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.

Abla A Konou1, Anoumou Y Dagnra, Nicole Vidal, Mounerou Salou, Zakillatou Adam, Assétina Singo-Tokofai, Eric Delaporte, Mireille Prince-David, Martine Peeters.   

Abstract

Information on efficacy of long-term antiretroviral treatment (ART) exposure in resource-limited countries is still scarce. In 767 patients attending routine HIV centers in Togo and receiving first-line ART for more than four years, 42% had viral load greater than 1000 copies/ml and either were on a completely ineffective ART regime or were with only a single drug active. The actual conditions to ensure lifelong ART in resource-limited countries can have dramatic long-term outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26558549     DOI: 10.1097/QAD.0000000000000906

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon.

Authors:  Emilande Guichet; Avelin Aghokeng; Sabrina Eymard-Duvernay; Nicole Vidal; Ahidjo Ayouba; Eitel Mpoudi Ngole; Eric Delaporte; Laura Ciaffi; Martine Peeters
Journal:  J Virol Methods       Date:  2016-09-05       Impact factor: 2.014

2.  Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa.

Authors:  Giovanni Villa; Adam Abdullahi; Dorcas Owusu; Colette Smith; Marilyn Azumah; Laila Sayeed; Harrison Austin; Dominic Awuah; Apostolos Beloukas; David Chadwick; Richard Phillips; Anna Maria Geretti
Journal:  EClinicalMedicine       Date:  2020-01-05

3.  Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.

Authors:  Kate El Bouzidi; Rawlings P Datir; Vivian Kwaghe; Sunando Roy; Dan Frampton; Judith Breuer; Obinna Ogbanufe; Fati Murtala-Ibrahim; Man Charurat; Patrick Dakum; Caroline A Sabin; Nicaise Ndembi; Ravindra K Gupta
Journal:  J Antimicrob Chemother       Date:  2022-02-02       Impact factor: 5.790

4.  High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.

Authors:  Mounerou Salou; Anoumou Y Dagnra; Christelle Butel; Nicole Vidal; Laetitia Serrano; Elom Takassi; Abla A Konou; Spero Houndenou; Nina Dapam; Assetina Singo-Tokofaï; Palokinam Pitche; Yao Atakouma; Mireille Prince-David; Eric Delaporte; Martine Peeters
Journal:  J Int AIDS Soc       Date:  2016-04-27       Impact factor: 5.396

5.  Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.

Authors:  Anne Derache; Collins C Iwuji; Siva Danaviah; Jennifer Giandhari; Anne-Geneviève Marcelin; Vincent Calvez; Tulio de Oliveira; François Dabis; Deenan Pillay; Ravindra K Gupta
Journal:  J Antimicrob Chemother       Date:  2019-02-01       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.